Transnasal Cooling Promising for Migraine

Paul M. George, MD, PhD, FAAN, Chair of the AAN Science Committee, discusses his selections for the most groundbreaking scientific research being presented at the 2025 AAN Annual Meeting, April 5-9 in San Diego. He was joined by the authors of three abstracts: Rajesh...

Conditioned room air delivered transnasally is safe, effective and tolerable for treatment of acute migraine, according to findings from a new study led by a Cleveland Clinic researcher. The results provide the first proof-of-concept for the Mi-Helper, a noninvasive...

SAN DIEGO -- An investigational device that delivered conditioned room air intranasally treated acute migraine attacks without drugs, a randomized sham-controlled study showed. Compared with sham, transnasal dry air flow at 10 L per minute using the Mi-Helper device...

SAN DIEGO — Significantly more patients with acute migraine who received a 10 L per minute dose of a transnasal cooling device had pain freedom at 2 hours vs. those who received sham, according to research presented at the AAN Annual Meeting. “There is a critical need...

By Marc Lallanilla - Read More Published Aug. 1, 2023 | Updated Aug. 1, 2023, 5:02 p.m. ET An innovative new treatment might soon help millions of people worldwide who suffer from migraines. Researchers have used a device that delivers a stream of air to...

Fran Lowry, June 27, 2023 Transnasal evaporative cooling appears promising as a nonpharmacologic treatment to abort migraine attacks, according to the results of a small study. Most patients reported relief of their symptoms after receiving 15 minutes of...

EAST LANSING, Mich. — Can shooting cool air up your nose stop or reduce migraines? Medical researchers at the Michigan State University College of Human Medicinethink it's possible, and they are conducting a study of a device that does just that. "Migraine is...

NEW YORK, March 16, 2023 /PRNewswire/ -- ObvioHealth and Mi-Helper, Inc. announce a partnership to conduct a decentralized clinical trial for a non-invasive neuromodulation device for the treatment of migraines. The randomized controlled trial will...